Lesson 3.6

Advanced Biological Interventions (ECT, TMS, & Esketamine)

As a Master Educator, I recognize that the frontiers of psychiatric care are rapidly expanding beyond traditional oral medications. In Ontario, when a client presents with treatment-resistant depression or acute suicidality that does not respond to standard psychotropics, we turn to advanced biological interventions. This page focuses on the nurse’s role in managing these high-impact therapies, ensuring they are deli

Learning objectives

Before you move on, be able to...

  • To conclude Section 3, can you:
  • State which procedural therapy for depression is covered by OHIP in Ontario?
  • Identify the theoretical mechanism (the growth factor) that Esketamine targets?
  • List the two most critical vital sign assessments during an Esketamine treatment?
  • Describe the mandatory post-administration safety rule for a client receiving nasal Esketamine?

Lesson block

The Clinical Frontier: Beyond Oral Psychotropics

Advanced biological interventions are indicated for individuals experiencing severe, life-threatening symptoms—such as catatonia or intense suicidal ideation—where traditional pharmacological options have failed. In Ontario, these procedures are recognized as essential medical care; for example, Electroconvulsive Therapy (ECT) is a standard procedure covered by OHIP.

Lesson block

Interactive Interface: "The Innovation Lab"

Procedural Tab 1: Electroconvulsive Therapy (ECT)

The Mechanism: Uses targeted electrical stimulation to brain areas to reset neurotransmitter function.

Nursing Priority: Informed consent is mandatory. Post-procedure, the nurse must monitor for common side effects such as transient memory loss and confusion.

Ontario Context: Health Sciences North (HSN) provides specialized video resources for clients to reduce the stigma surrounding this treatment.

Procedural Tab 2: Transcranial Magnetic Stimulation (TMS)

The Mechanism: A non-invasive brain stimulation therapy that uses electromagnetic pulses to stimulate nerve cells in the brain to improve symptoms of depression.

Nursing Priority: Unlike ECT, TMS typically does not require anesthesia or a recovery period, allowing for safer application in outpatient settings.

Procedural Tab 3: Esketamine (The Innovation)

Lesson block

Deep Dive: The Esketamine Clinic Flow

Esketamine management represents a unique shift in nursing workflow due to its delivery method and monitoring requirements.

Administration: It is a self-administered nasal spray (28 mg dose) given in a clinic setting.

Monitoring Period: After administration, the client must remain in the clinic for 40 minutes to one hour for observation.

Safety Warning: Because side effects can include depersonalization, derealization, vertigo, and sedation, the client must not drive home and requires a designated driver.

Treatment Course: Typically lasts up to 10 weeks, with one or two treatments per week.

Lesson block

Clinical Toolkit: Pre- and Post-Intervention Assessment

Nurses at the expert level must bridge the gap between biological stability and psychiatric recovery.

Assessment Component

ECT/TMS Priority

Esketamine Priority

Vital Signs

Monitor for post-ictal tachycardia.

Monitor for acute increases in Blood Pressure.

Cognitive Status

Lesson block

Future Horizons: Digital Monitoring of Biological Response

Ontario facilities, such as the Timmins and District Hospital, are integrating digital tools like SeamlessMD to track client symptoms between treatments. These tools allow clients to report changes in mood or suicidal thoughts via surveys, providing real-time data that can inform the timing and frequency of biological interventions like Esketamine.

Practice transfer

Apply this before the next lesson

Write one sentence you would say to a patient, one sentence you would document, and one question you would bring to supervision or team handoff.